TrialJournal of gastrointestinal cancer2007

Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.

Steven R Alberts et al.PubMed ↗Publisher ↗

No numbers read from the abstract.